HopeStage
Back to all studies
CompletedNCT04310423

Inflammation and Craving After an Endotoxin Challenge

About this titleRead the official source — NCT04310423
Placebo comparisonAges 21–45United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 45 years.

Listed locations
Los AngelesSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 19, 2021
Recruitment status
Completed
Enrollment listed in the registry
20
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Biological
Intervention type
BIOLOGICAL, Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 45 Years
Official registry ID
NCT04310423
Official title
Show the full official title

An Inflammatory Challenge Using Endotoxin

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Los Angeles

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Did this study involve medication?

Yes. The study involved medication, including Placebo.

Who was this study for?

Listed age limits: 21 years to 45 years.

Want to explore more studies?

Explore studies